Key Takeaways
- AUM crossed INR 1 lakh crore, up 26% YoY: The milestone was reached in the company's seventh/eighth year, but disbursements declined YoY due to two large LRD transactions in the base quarter.
- NIM improved QoQ to 4.1% despite cost-of-funds pressure: Portfolio yield held steady at 9.9% while the 5 bps QoQ rise in cost of funds was absorbed; gross spread compressed 40 bps YoY to 1.9%.
- Credit cost optically low at 2 bps on overlay release: Normalized credit cost runs 14-16 bps, and the remaining discretionary overlay is only INR 10 crores, so normalization is likely next quarter.
- IPO proceeds of INR 1,500 crores were unutilized at quarter-end: The capital raise depressed ROE to 13% from 16%; deployment was expected during October, and leverage is targeted at 8x.
- What to watch next quarter: Whether the affordable and near-prime verticals lift retail disbursement growth, the pace of credit cost normalization once the overlay is exhausted, and the trajectory of cost of funds now that low-cost NCD repricing has largely played out.
AUM Growth & Disbursement Trends
- AUM milestone: The portfolio crossed INR 100,000 crores with 26% YoY growth, while the mix stayed broadly stable: home loans dipped 1%, developer construction finance rose 2%, and LAP and LRD were largely unchanged.
- Disbursement softness: Q2 disbursements were slightly lower YoY, driven entirely by the LRD segment where the base quarter had two marquee large transactions; retail disbursements grew 7% YoY while commercial declined 9%.
- Retail pickup expected: The affordable and near-prime segments have gone live and started delivering numbers, so management expects retail disbursements to pick up, though no quantified timeline was given.
- Competitive intensity unchanged: Prime home loan competition has been intense for six to seven years and is expected to remain so; the company sources largely at the developer counter or through distribution partners rather than relying on branch walk-ins.
Jain: "Competition in the home loan, in the prime home loan remains very intense, which all of us remain. But that had been the status from last six seven years, ever since we started the business and expected to remain intense."
Margins, Spreads & Cost of Funds
- NIM improved sequentially: NIM moved from 3.9% to 4.1% QoQ, helped by operating efficiency gains where opex-to-NTI improved to 20.5% from 22.1% YoY.
- Gross spread compressed YoY: Spread fell from 2.3% to 1.9% as cost of funds rose 28 bps YoY to 7.9% while portfolio yield remained steady at 9.9%.
- Cost-of-funds repricing largely done: The drag from maturing low-cost NCDs and the pass-through of rate hikes has structurally played out; less than INR 300-400 crores of low-cost NCDs remain to be retired.
- Repo-linked book is match-funded: Approximately INR 13,000-15,000 crores of assets are repo-linked and are closely matched by repo-linked liabilities, insulating that portion from basis risk.
- Capital raise does not affect spread: The INR 2,000 crore rights issue in Q1 and the IPO proceeds do not change gross spread; they affect leverage and absolute profit, and the IPO money was unutilized as of September 30.
Jain: "In the cost of fund side, by and large, whatever you can say the implication of either the earlier low-cost NCD maturing or the pricing, the peaking out of the pass through in the cost of fund, that has happened."
Asset Quality & Credit Cost
- Stage 2 assets halved YoY: Stage 2 declined from 0.57% to 0.32%, while Stage 1 assets remained stable above 99.35%; GNPA and NNPA continue to be strong.
- Reported credit cost optically low: The 2 bps reported credit cost reflects overlay release; net of that release, the normalized run-rate is 14-16 bps and has been stable for four to five quarters.
- Normalization imminent: Only INR 10 crores of discretionary overlay remains, so the reported credit cost should converge to the 14-16 bps normalized level, possibly as early as next quarter.
- LRD provisioning is conservative: The INR 14,000 crore LRD book has never had a Stage 2 or Stage 3 asset, yet carries 0.61% ECL provisioning, which management describes as significantly higher than what ECL models require; some overlay release was used to strengthen Stage 1 coverage here.
- Stage 1 PCR decline is mix-driven, not model-driven: The decline in consolidated Stage 1 coverage was caused by overlay consumption and asset mix shifts, not changes to the ECL model; commercial assets like LRD and construction finance carry higher ECL Stage 1 than home loans, so faster home loan growth mechanically reduces the consolidated coverage ratio.
Jain: "0.61% kind of a ECL provisioning is significantly higher provisioning than whatever ECL models do that."
Portfolio Composition & Product Dynamics
| Product | Mix & Trend | Commentary |
|---|---|---|
| Home Loans | ▼ 1% to ~57% of AUM | Prime segment faces intense competition; Flexi/OD not permitted by regulation except in the top-up portion of balance transfers. |
| Loan Against Property | ▼ 1% | Average ticket INR 80 lakh-1 crore, mostly to self-employed for business purposes; Dropline Flexi is offered here. Considered lower priority vs home loans given HFC regulatory requirements. |
| Lease Rental Discounting | ▬ Stable at ~INR 14,000 cr | Zero Stage 2/3 assets historically; doubly secured by cashflows and property. No internal cap but regulatory cap applies (60%+ of assets must be residential). |
| Developer Construction Finance | ▲ Up 2% | Portfolio attrition uptick driven by high residential sales and pre-agreed sweep ratios per project stage; 0.62% Stage 1 provisioning considered reasonable. |
- Affordable and near-prime now live: The company uses "prime" (easily bankable, largely salaried, good FOIR and collateral) and "non-prime" for everything else; there is no standard industry definition of "affordable." The non-prime vertical has gone live and is expected to support retail disbursement pickup.
- Portfolio attrition is mix-driven: The uptick in overall attrition over the last year is driven by the construction finance portfolio where sweeps accelerate as projects sell down; retail portfolio attrition has been stable for 34 quarters.
Liability Structure & Leverage
- Leverage target of 8x: Management stated 8x is the sustainable leverage metric and will track toward it as capital is deployed; when leverage rises and capital is utilized, the company will look to raise capital again.
- IPO proceeds deployment: INR 1,500 crores from the September 16 listing was unutilized at quarter-end and was expected to be deployed during October 2024.
- ROA in a stable band: Excluding FY23, ROA has been stable between 2.3% and 2.6% across quarters; the capital raise had a minuscule impact on Q2 ROA given the late-quarter listing date.
- ROE optically depressed: ROE fell from 16% to 13% due to the equity infusion from the capital raise, not due to operating deterioration.
Disclosures & Regulatory Context
- Maiden earnings call: This was the company's first earnings conference call and first equity investor presentation deck following the September 16 IPO.
- Regulatory silent period: Management is operating under a 40-day silent period as advised by legal counsel, which constrained forward-looking statements throughout the call.
- Disbursement data to be disclosed: Management committed to including disbursement numbers in disclosures from next quarter onward, after not having the data point ready during the call.
- Employee mix shift: The company changed its strategy around one to one-and-a-half years ago, moving entry-level non-managerial positions to contractual employees through manpower outsourcing partners; absolute off-role numbers were not shared on the call.
Jain: "We are operating in one -- a bit of a construct because we are yet not out from the publicity guideline for future looking there. But I'll say that we are, because we are still in regulatory silent period, because this is a 40 days as advised by legal counsel to us."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Credit cost normalization | Remaining overlay only INR 10 crores; normalized run-rate 14-16 bps | Possibly next quarter |
| Disbursement data disclosure | Will include disbursement numbers in reporting | From next quarter onward |
| IPO proceeds deployment | INR 1,500 crores unutilized as of Sep 30 to be deployed | During October 2024 |
| Leverage target | Track at 8x leverage ratio | Ongoing |
| Cost-of-funds repricing | Low-cost NCD maturities largely done; less than INR 300-400 cr remaining | Largely behind |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| AUM | ₹1,02,569 cr, +26% YoY |
| PBT | ₹708 cr, +23% YoY |
| PAT | +21% YoY, lower than PBT growth due to prior-year tax adjustment |
| Gross portfolio yield | 9.9%, steady from Q2 FY24 to Q2 FY25 |
| Cost of funds | 7.92%, +5 bps QoQ and +28 bps YoY |
| Gross spread | 1.9%, stable QoQ; was 2.3% in Q2 FY24 |
| NIM | 4.1%, improved from 3.9% in Q1 FY25; was 4.4% in Q2 FY24 |
| Opex to NTI | 20.5%, improved from 22.1% in Q2 FY24 |
| ROA | 2.5%, nearly same as 2.6% in Q2 FY24 |
| ROE | 13%, down from 16% in Q2 FY24 due to capital raise |
| Capital adequacy | 28.98%, up significantly from regulatory requirement of 15% after IPO |
| GNPA | 29 bps |
| NNPA | 12 bps |
| Credit cost | 2 bps reported; 14 bps net of overlay release |
| Home loan AUM growth | 24% YoY |
| Loan against property AUM growth | 18% YoY |
| Lease rental discounting AUM growth | 28% YoY |
| Developer finance AUM growth | 56% YoY |
| Retail disbursement growth | ~7% YoY |
| Commercial disbursement growth | -9% YoY |
| Stage 2 assets | 0.32%, down from 0.57% in Q4 FY23 |
| PCR on Stage 3 assets | 57%–59%, range bound |
| Borrowing mix | 44% banks, 43% NCDs, 1.6% CP, 11% NHB |
| Leverage ratio threshold | 8x, currently lower due to capital raises |
| IPO proceeds unutilized | ₹1,500 cr as of 30 Sep 2024, expected deployment in Oct 2024 |